Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Eye (London, England)|May 30, 2020
Prospective deep phenotyping of choroideremia patients using multimodal structure-function approachesAhmed M Hagag, Andreas Mitsios, Akshay Narayan, et al.
Surgical Neurology International|December 6, 2017
Aplasia cutis congenita: Two case reports and discussion of the literatureAlexandros Blionas, Dimitrios Giakoumettis, Elias Antoniades, et al.
Ocular Immunology and Inflammation|May 4, 2023
Non-Healing Corneal Ulcer and Uveitis Following Monkeypox Disease: Diagnostic and Therapeutic ChallengesSofia Androudi, Aaron R Kaufman, Alexandros Kouvalakis, et al.
Human Molecular Genetics|January 29, 2019
Nonsense-mediated mRNA decay efficiency varies in choroideremia providing a target to boost small molecule therapeuticsHajrah Sarkar, Andreas Mitsios, Matthew Smart, et al.
The British Journal of Ophthalmology|July 4, 2019
Characterisation of microvascular abnormalities using OCT angiography in patients with biallelic variants in USH2A and MYO7AAhmed M Hagag, Andreas Mitsios, Jasdeep S Gill, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 22, 2023
Histone H3K9 methyltransferase SETDB1 overexpression correlates with pediatric high-grade gliomas progression and prognosisAlexia Klonou, Penelope Korkolopoulou, Angeliki-Ioanna Giannopoulou, et al.
JCI Insight|March 23, 2021
REP1 deficiency causes systemic dysfunction of lipid metabolism and oxidative stress in choroideremiaDulce Lima Cunha, Rose Richardson, Dhani Tracey-White, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 6, 2025
SUV39H1 regulates progression of pediatric diffuse high-grade gliomas through modulation of β-catenin/TCF4 levelsAlexia Klonou, Angeliki-Ioanna Giannopoulou, Christos Adamopoulos, et al.
Human Molecular Genetics|January 31, 2020
Clinical and preclinical therapeutic outcome metrics for USH2A-related diseaseMaria Toms, Adam M Dubis, Erik de Vrieze, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 23, 2021
Histone Mark Profiling in Pediatric Astrocytomas Reveals Prognostic Significance of H3K9 Trimethylation and Histone Methyltransferase SUV39H1Alexia Klonou, Penelope Korkolopoulou, Antonios N Gargalionis, et al.
Pageof 3